Skip to main content

Table 1 Patient characteristics

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD Controls p value
N = 63 N = 26
Male, n (%) 63 (100) 26 (100) 1.00
Age, years 31 ± 15 36 ± 13 0.09
BMI, kg/m2 24 ± 4 25 ± 3 0.36
Skeletal muscle status 0/1/2/3, n (%) 2 (3)/43 (68)/13 (21)/5 (8) 26 (100)/0 (0)/0 (0)/0 (0) <0.0001
Hypertension, n (%) 3 (5) 0 (0) 0.55
Diabetes, n (%) 0 (0) 0 (0) 1.00
ACE inhibitor, n (%) 16 (25) 0 (0) 0.005
Beta-blocker, n (%) 14 (22) 0 (0) 0.008
CK, U/L 1226 (653–2424) 120 (99–169) <0.0001
Elevated hs-Trop, n (%) 30 (48) 0 (0) <0.0001
Elevated NT-proBNP, n (%) 3 (5) 0 (0) 0.55
  1. Bold text indicates a significant p-value of <0.05